Sharon Calvert

A phase IB safety and pharmacokinetic (PK) study of recombinant human Apo2L/TRAIL in combination with rituximab in patients with low-grade non-Hodgkin lymphoma

Lorrin Yee, Michelle A. Fanale, K. Dimick et al. · Journal of Clinical Oncology · 2007 · 65 citations

Medicine, Pharmacokinetics, Pharmacology +17

Gemcitabine in the Second-Line Therapy of Patients with Carcinoma of Unknown Primary Site: A Phase II Trial of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Howard A. Burris, Sharon Calvert et al. · Cancer Investigation · 2001 · 52 citations

Medicine, Oncology, Pharmacology +11

Site specific lymph node metastasis in carcinoma of the cervix: Is there a sentinel node?

K. S. Metcalf, Nick Johnson, Sharon Calvert et al. · International Journal of Gynecological Cancer · 2000 · 26 citations

Medicine, Oncology, Surgery +17

Phase I Study of JM-216 (an Oral Platinum Analogue) in Combination with Paclitaxel in Patients with Advanced Malignancies

Suzanne Jones, John D. Hainsworth, Howard A. Burris et al. · Investigational New Drugs · 2002 · 17 citations

Medicine, Oncology, Pharmacology +13